Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement, Infant Formula Acceptable Claims Not Equivalent – NCL

This article was originally published in The Tan Sheet

Executive Summary

Claims approved for dietary supplements containing DHA may not be suitable for DHA- and ARA-fortified infant formulas, the National Consumers League says in a Feb. 5 letter to the National Advertising Division of the Council of Better Business Bureaus

You may also be interested in...



Mead DHA/ARA-Fortified Infant Formula Slated For February Release

Mead Johnson Nutritionals' Enfamil LIPIL, an infant formula fortified with ARA and DHA fatty acid oils, will be priced in the U.S. at a 10%-15% premium to the line's Enfamil with Iron product, the firm said

Neuromins DHA Claims Not Supported By Infant Formula Data, NAD Finds

Data showing DHA-fortified infant formulas help improve babies' cognitive development are not adequate to substantiate similar claims made for DHA-containing dietary supplements taken by pregnant or nursing mothers, NAD states in its June Case Reports.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS093675

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel